Evidence map›Paper›PMID 30869651›Full record

ArticleJMIR mHealth and uHealth2019

Perspectives on Acceptance and Use of a Mobile Health Intervention for the Prevention of Atherosclerotic Cardiovascular Disease in Singapore: Mixed-Methods Study.

Victoria Haldane, Yao Guo Tan, Krichelle Wei Qi Teo, Joel Jun Kai Koh, Aastha Srivastava, Rui Xiang Cheng, Yi Cheng Yap, Pei-Shi Ong, Rob M van Dam, Jie Min Foo and 4 more

Open access · goldAbstract read
In one paragraph

Article in JMIR mHealth and uHealth, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
1.7field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Atherosclerotic cardiovascular disease landscape in Singapore.Frontiers in cardiovascular medicine · 2024
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 4 countries.

Victoria Haldane *Institute of Health Policy, Management & Evaluation, University of Toronto, Toronto, ON, Canada.ORCID 0000-0002-8674-4099
Yao Guo Tan *Department of Pharmacy, National University of Singapore, Singapore, Singapore.ORCID 0000-0002-9139-6340
Krichelle Wei Qi Teo *Department of Pharmacy, National University of Singapore, Singapore, Singapore.ORCID 0000-0002-5106-6937
Joel Jun Kai KohInstitute of Health Policy, Management & Evaluation, University of Toronto, Toronto, ON, Canada.ORCID 0000-0003-3488-8119
Aastha SrivastavaInstitute of Health Policy, Management & Evaluation, University of Toronto, Toronto, ON, Canada.ORCID 0000-0002-8405-5898
Rui Xiang ChengDepartment of Pharmacy, National University of Singapore, Singapore, Singapore.ORCID 0000-0003-4074-8710
Yi Cheng YapDepartment of Pharmacy, National University of Singapore, Singapore, Singapore.ORCID 0000-0002-3613-5121
Pei-Shi OngDepartment of Pharmacy, National University of Singapore, Singapore, Singapore.ORCID 0000-0003-1679-6640
Rob M van DamInstitute of Health Policy, Management & Evaluation, University of Toronto, Toronto, ON, Canada.ORCID 0000-0002-7354-8734
Jie Min FooInstitute of Health Policy, Management & Evaluation, University of Toronto, Toronto, ON, Canada.ORCID 0000-0002-7992-9511
Falk Müller-RiemenschneiderInstitute of Health Policy, Management & Evaluation, University of Toronto, Toronto, ON, Canada.ORCID 0000-0003-1402-7477
Gerald Choon-Huat KohInstitute of Health Policy, Management & Evaluation, University of Toronto, Toronto, ON, Canada.ORCID 0000-0002-6453-6897
Pablo PerelLondon School of Hygiene and Tropical Medicine, London, United Kingdom.ORCID 0000-0002-2342-301X
Helena Legido-QuigleyInstitute of Health Policy, Management & Evaluation, University of Toronto, Toronto, ON, Canada.ORCID 0000-0003-4113-4542
University of Toronto · CANational University of Singapore · SGLondon School of Hygiene & Tropical Medicine · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCardiovascular disease, including atherosclerotic cardiovascular disease (ASCVD), is a growing public health threat globally and many individuals remain undiagnosed, untreated, and uncontrolled. Simultaneously, mobile health (mHealth) interventions using short messaging service (SMS) have gained popularity globally. There is an opportunity for innovative approaches such as mHealth to encourage and enable adherence to medications for ASCVD and its risk factors.

objectiveThis study aimed to understand mobile technology acceptance, use, and facilitating conditions among the study population ahead of the design of an mHealth intervention.

methodsUsing data from a mixed-methods study conducted in Singapore, we conducted a cross-sectional survey with 100 participants and in-depth, semistructured interviews with 20 patients. All participants were over the age of 40 years with ASCVD or its risk factors. Interviews were conducted in English and Mandarin and if needed translated to English. Nvivo 11 (QSR International) was used for analyses.

resultsParticipants reported their perspectives on technology use and preferences, including low or sporadic mobile phone use and usability concerns including small screen and text size, among others; the benefit of previous mHealth use in creating a favorable opinion of SMS for health information; trust in both the source of mHealth SMS, as well as in treatment; the formation of habits; and fear of sequelae or death for facilitating intention to use an mHealth intervention and adhere to medication. We also highlighted a case that underscored the importance of the period after diagnosis in habit forming as an opportunity for an mHealth intervention.

conclusionsWe explored both technology- and adherence-related factors that influence a patient's intention to use an mHealth intervention for adherence to ASCVD medication in Singapore. We highlighted the importance of identifying the right opportunity to engage with patients and promote an mHealth intervention for adherence, such as immediately following diagnosis when patients are establishing medication-taking habits.

Indexed as

AgedAged, 80 and overCardiovascular DiseasesCross-Sectional StudiesFemaleHumansInterviews as TopicMaleMiddle AgedPatient Acceptance of Health CareQualitative ResearchSingaporeSurveys and QuestionnairesTelemedicineatherosclerosiseHealthmedication adherencemHealthpatient acceptance of health carepatient-centered care

Identifiers

PMID30869651
PMCPMC6437612
OpenAlexW2898359643

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.